Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators (Q84160301)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22605518%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22605518%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

7

Huamin Wang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22605518%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

James Lewis Abbruzzese

8

object named as

James Abbruzzese

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22605518%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

2

Jason B Fleming

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22605518%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Matthew H G Katz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22605518%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Priya Bhosale

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22605518%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Gauri Varadhachary

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22605518%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Jeffrey E Lee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22605518%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Robert Wolff

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22605518%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Peter W T Pisters

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22605518%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Jean-Nicolas Vauthey

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22605518%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Chusilp Charnsangavej

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22605518%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Eric Tamm

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22605518%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Christopher H Crane

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22605518%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Aparna Balachandran

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22605518%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

17 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22605518%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

number of pages

8

1 reference

inferred from page(s)

published in

Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22605518%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22605518%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22605518%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

5749-5756

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22605518%20AND%20SRC:MED&resulttype=core&format=json

Breast conservation after neoadjuvant chemotherapy

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27636

7 January 2021

Can we increase the chance of sphincter saving surgery in rectal cancer with neoadjuvant treatments: lessons from a systematic review of recent randomized trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27636

7 January 2021

Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27636

7 January 2021

Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27636

7 January 2021

Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27636

7 January 2021

Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27636

7 January 2021

Borderline resectable pancreatic cancer: the importance of this emerging stage of disease.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27636

7 January 2021

Defining venous involvement in borderline resectable pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27636

7 January 2021

Borderline resectable pancreatic cancer: what have we learned and where do we go from here?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27636

7 January 2021

Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27636

7 January 2021

Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27636

7 January 2021

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27636

7 January 2021

Effect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27636

7 January 2021

Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27636

7 January 2021

Downstaging chemotherapy and alteration in the classic computed tomography/magnetic resonance imaging signs of vascular involvement in patients with pancreaticobiliary malignant tumors: influence on patient selection for surgery.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27636

7 January 2021

A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27636

7 January 2021

Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27636

7 January 2021

Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27636

7 January 2021

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27636

7 January 2021

Identifiers

DOI

10.1002/CNCR.27636

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22605518%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference